Modulation of protease-activated receptor expression by Porphyromonas gingivalis in human gingival epithelial cells

BMC Oral Health

Lili Chen¹  Lieping Sheng²  Lingjing Hu¹  Shenglai Li³  Diya Zhang² 

[1] Department of Oral Medicine, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China;Dental Department, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China;Department of Oral and Maxillofacial Surgery, Stomatology Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China

关键词: Proteases;    Porphyromonas gingivalis;    Human gingival epithelial cells;    Protease-activated receptor;   

Others  :  1228766
DOI  :  10.1186/s12903-015-0105-8

 received in 2015-06-10, accepted in 2015-10-05,  发布年份 2015

【 摘 要 】

Background

Protease-activated receptors (PARs) are G-protein-coupled receptors with an active role in mediating inflammation, pain and other functions. The oral pathogen Porphyromonas gingivalis (P. gingivalis) secretes proteases that activate PARs. The aim of this study was to elucidate the role of PARs in the pathogenesis of chronic periodontitis by expression analysis of PARs in human gingival epithelial cells (GECs) before and after P. gingivalis supernatants treatment.

Methods

GECs were isolated from healthy human gingival tissue samples. The expression of PARs in GECs was determined by reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry. The effect of P. gingivalis proteases was investigated by quantitative real-time reverse transcription polymerase chain reaction (QRT-PCR) and flow cytometry.

Results

PAR-1, PAR-2, and PAR-3 were expressed in GECs. PAR-4 was not found by both RT-PCR and flow cytometry. Analysis of gene expression using QRT-PCR showed an up-regulation of PAR-2 mRNA in comparison to the untreated control cells (P < 0.05). In contrast, the mRNA expressions of PAR-1 and PAR-3 were significantly down-regulated (P > 0.05) in response to P. gingivalis supernatant compared to that in unstimulated control cells. This effect was abrogated by the protease inhibitor TLCK (P < 0.05). The results of flow cytometry indicated PARs protein levels consistent with mRNA levels in the results of QRT-PCR.

Conclusions

Our study shows that PAR-1, PAR-2 and PAR-3 are expressed in GECs. P. gingivalis proteases play a role in the regulation of innate immune responses in GECs. GECs use PARs to recognize P. gingivalis and mediate cell responses involved in innate immunity.

【 授权许可】

   
2015 Zhang et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Figure 1.

【 参考文献 】

• [1]Gieseler F, Ungefroren H, Settmacher U, Hollenberg MD, Kaufmann R. Proteinase-activated receptor (PARs)--focus on receptor-receptor-interations and their physiological and pathophysiological impact. Cell Commun Signal. 2013; 11(1):86. BioMed Central Full Text
• [2]Knecht W, Cottrell GS, Amadesi S, Mohlin J, Skaregӓrde A, Gedda K et al.. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J Biol Chem. 2007; 282(36):26089-26100.
• [3]Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ et al.. Cleavage and activation of proteinase activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett. 1998; 435(1):45-48.
• [4]Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost. 2006; 32 Suppl 1:39-48.
• [5]Coughlin SR, Camerer E. Participation in inflammation. J Clin Invest. 2003; 111(1):25-27.
• [6]Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A. 2000; 97(10):5255-5260.
• [7]Cottrell GS, Amadesi S, Grady EF, Bunnett NW. Trypsin IV: A novel agonist of protease-activated receptors 2 and 4. J Biol Chem. 2004; 279(14):13532-13539.
• [8]Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem. 2000; 275(10):6819-6823.
• [9]Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C et al.. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997; 386(6624):502-506.
• [10]Gorr SU. Antimicrobial peptides in periodontal innate defense. Front Oral Biol. 2012; 15:84-98.
• [11]Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med. 1998; 9(4):399-414.
• [12]Hasebe A, Yoshimura A, Into T, Kataoka H, Tanaka S, Arakawa S et al.. Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease. Infect Immun. 2004; 72(3):1318-25.
• [13]Janardhanam SB, Prakasam S, Swaminathan VT, Kodumudi KN, Zunt SL, Srinivasan M. Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus. Arch Oral Biol. 2012; 57(5):495-502.
• [14]Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R et al.. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood. 2001; 97(12):3790-3797.
• [15]Holzhausen M, Spolidorio LC, Ellen RP, Jobin MC, Steinhoff M, Andrade-Gordon P et al.. Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am J Pathol. 2006; 168(4):1189-1199.
• [16]Holzhausen M, Spolidorio LC, Vergnolle N. Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats. J Dent Res. 2005; 84(2):154-159.
• [17]Lourbakos A, Potempa J, Travis J, D’Andrea MR, Andrade-Gordon P, Santulli R et al.. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun. 2001; 69(8):5121-5130.
• [18]Zhang D, Li S, Hu L, Sheng L, Cao Z, Wu Y et al.. Protease-activated receptors expression in gingiva in periodontal health and disease. Arch Oral Biol. 2014; 59(4):393-399.
• [19]O’Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire. Curr protein Prept Sci. 2003; 4:409-426.
• [20]Pathirana RD, O’Brien-Simpson NM, Visvanathan K, Hamilton JA, Reynolds EC. The role of the RgpAc–Kgp proteinase–adhesion complexes in the adherence of Porphyromonas gingivalis to fibroblasts. Microbiology. 2008; 154:2904-1911.
• [21]Fujimura S, Hirai K, Shibata Y, Nakayama K, Nakamura T. Comparative properties of envelope-associated arginine-gingipains and lysine-gingipain of Porphyromonas gingivalis. FEMS Microbiol Lett. 1998; 163(2):173-179.
• [22]Dommisch H, Chung WO, Rohani MG, Williams D, Rangarajan M, Curtis MA et al.. Protease-activated receptor 2 mediates human betadefensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis. Infect Immun. 2007; 75(9):4326-4333.
• [23]Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001; 25(4):402-408.
• [24]Lindner JR, Kahn ML, Coughlin SR, Sambrano GR, Schauble E, Bernstein D et al.. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol. 2000; 165(11):6504-6510.
• [25]Uehara A, Imamura T, Potempa J, Travis J, Takada H. Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol. 2008; 10(5):1181-1189.
• [26]Euzebio Alves VT, da Silva HA B, de Franca BN, Eichler RS, Saraiva L, de Carvalho MH et al.. Periodontal treatment downregulaters protease-activated receptor 2 in human gingival crevicular fluids cells. Infect imunn. 2013; 81(12):4399-4407.
• [27]Chung WO, Hansen SR, Rao D, Dale BA. Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J Immunol. 2004; 173(8):5165-5170.
• [28]Rohani MG, Beyer RP, Hacker BM, Dommisch H, Dale BA, Chung WO. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells. Innate Immun. 2010; 16(2):104-114.
• [29]Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trend pharmacol Sci. 2001; 22(3):146-152.
• [30]Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004; 84(2):579-621.
• [31]Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, Meek SE et al.. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest. 2003; 111(1):35-41.
• [32]Morla L, Brideau G, Fila M, Crambert G, Cheval L, Houillier P et al.. Renal proteinase-activated receptor 2, a new actor in the control of blood pressure and plasma potassium level. J Biol Chem. 2013; 288(14):10124-10131.
• [33]Holzhausen M, Cortelli JR, da Silva VA, Franco GCN, Cortelli SC, Vergnolle N. Protease-activated receptor-2 (PAR2) in human periodontitis. J Dental Res. 2010; 89(9):948-953.
• [34]Fagundes JA, Monoo LD, Euzebio Alves VT, Pannuti CM, Cortelli SC, Cortelli JR et al.. Porphyromonas gingivalis is associated with protease-activated receptor-2 up-regulation in chronic periodontitis. J Periodontol. 2011; 82(11):1596-1601.
• [35]Junge CE, Lee CJ, Hubbard KB, Zhang A, Olson JJ, Hepler JR et al.. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp Neurol. 2004; 188(1):94-103.
• [36]Pompili E, Fabrizi C, Nori AL, Panetta B, Geloso MC, Corvino V et al.. Protease-activated receptor-1 expression in rat microglia after trimethyltin treatment. J Histochem Cytochem. 2011; 59(3):302-311.
• [37]Vellani V, Kinsey AM, Prandini M, Hechtfischer SC, Reeh P, Magherini PC et al.. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Mol Pain. 2010; 6:61. BioMed Central Full Text
• [38]da Silva HA, Euzebio Alves VT, Spolidório LC, César Neto JB, Eichler RS, de Carvalho MH C et al.. Expression of Protease Activated Receptor-1 in Chronic Periodontitis. J Periodontol. 2014; 85(12):1763-1769.
• [39]Hansen KK, Saifeddine M, Hollenberg MD. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells. Immunology. 2004; 112(2):183-190.
• [40]Kaufmann R, Schulze B, Krause G, Mayr LM, Settmacher U, Henklein P. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFGAP interacts with PAR1. Regul Pept. 2005; 125(1–3):61-66.
• [41]McLaughlin JN, Patterson MM, Malik AB. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci U S A. 2007; 104(13):5662-5667.
• [42]Lu C, Zhao FD, Li XB, Yin LH. Up regulation of interleukin-8 expressions induced by mast cell tryptase via protease activated receptor-2 in endothelial cell line. Chin med J (Engl). 2005; 118(22):1900-1906.
• [43]Kawabata A, Nishikawa H, Saitoh H, Nakaya Y, Hiramatsu K, Kubo S et al.. A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology. 2004; 126(1):208-219.